home / stock / xrtxf / xrtxf news

XRTXF News and Press, XORTX Therapeutics Inc From 09/19/19

Stock Information
Company Name: XORTX Therapeutics Inc
Stock Symbol: XRTXF
Market: OTC
Website: xortx.com
Menu
XRTXF XRTXF Quote XRTXF Short XRTXF News XRTXF Articles XRTXF Message Board
Get XRTXF Alerts

News, Short Squeeze, Breakout and More Instantly...
XRTXF - XORTX Announces Positive Phase 2 Results in Type 2 Diabetic Nephropathy (T2DN)

● TMX-049 Results Show Beneficial Decrease of Urinary Albumin in T2DN ● CALGARY, Alberta, Sept. 19, 2019 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. (" XORTX " or the “ Company ”) (CSE: XRX; OTCQB: XRTXF), a biopharmaceutical company focused on developing inn...
XRTXF - XORTX Highlights New Research on Polycystic Kidney Disease Awareness Day

● New Study Shows a Novel Form of Injury Linking Uric Acid Crystals in Urine and ADPKD Progression ● CALGARY, Alberta, Sept. 04, 2019 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. (" XORTX " or the “ Company ”) (CSE: XRX; OTCQB: XRTXF; ANU1: FWB), a biopharmace...

XRTXF - OTCQB Venture Company Investor Presentations Now Available for On-Demand Viewing

NEW YORK , Aug. 5, 2019 /PRNewswire/ -- Virtual Investor Conferences, the leading proprietary investor conference series, today announced that the presentations from the August 1, 2019 OTCQB Venture Company Conference are now available for on-demand viewing at VirtualInvestorConfer...

XRTXF - Live OTCQB Venture Company Investor Conference August 1st

Live OTCQB Venture Company Investor Conference August 1st Canada NewsWire NEW YORK, July 30, 2019 Company executives will share vision and answer audience questions at VirtualInvestorConferences.com NEW YORK , July 30, 2019 /CNW/ - Virtual Investor Conferences today a...
XRTXF - XORTX Announces Virtual Investor Conference Live Webcast

CALGARY, Alberta , July 30, 2019 /PRNewswire/ --   XORTX Therapeutics Inc. (" XORTX " or the " Company ") (CSE: XRX; OTCQB: XRTXF; ANU1: FWB), a biopharmaceutical company focused on developing innovative therapies to treat progressive kidney disease, is pleased to announce ...

XRTXF - XORTX Reports Annual & Special Meeting Results

CALGARY, Alberta, July 18, 2019 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. (" XORTX " or the “ Company ”) (CSE: XRX; OTCQB: XRTXF; ANU1: FWB), a biopharmaceutical company focused on developing innovative therapies to treat progressive kidney disease, is pleased to announce th...

XRTXF - XORTX Shares Nature Nephrology Review

CALGARY, Alberta, July 15, 2019 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. (" XORTX " or the “ Company ”) (CSE: XRX; OTCQB: XRTXF; ANU1: FWB), a biopharmaceutical company focused on developing innovative therapies to treat progressive kidney disease, is pleased to recognize a...
XRTXF - XORTX Provides Overview and Announces $5 Million Financing to Advance Clinical Trials

CALGARY, Alberta, April 29, 2019 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. (" XORTX " or the “ Company ”) (CSE: XRX; OTCQB: XRTXF), a biopharmaceutical company focused on developing innovative therapies to treat progressive kidney disease, confirms that the Company has filed...

XRTXF - XORTX Shares Findings of Diabetes Study in Youths Supporting High Uric Acid Advances Kidney Disease Progression

CALGARY, Alberta, April 16, 2019 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. (" XORTX " or the “ Company ”) (CSE: XRX; OTCQB: XRTXF), a biopharmaceutical company focused on developing innovative therapies to treat progressive kidney disease, congratulates the TODAY study team ...

XRTXF - XORTX Shares Findings of New Diabetes Study Supporting Uric Acid as an Independent Risk Factor

CALGARY, Alberta, March 25, 2019 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. (" XORTX " or the “ Company ”) (CSE: XRX; OTCQB: XRTXF), a biopharmaceutical company focused on developing innovative therapies to treat progressive kidney disease, is pleased to highlight a recent an...
Previous 10 Next 10